Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Haematologica|November 11, 2017
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromesLouise de Swart, Chloé Reiniers, Timothy Bagguley, et al.Annals of Hematology|July 3, 2026
Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in GreeceEpameinondas Koumpis, Eva Minga, Persefoni Talimtzi, et al.Immunogenetics|November 13, 2014
Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemiaAliki Xochelli, Andreas Agathangelidis, Ioannis Kavakiotis, et al.Blood|December 18, 2015
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutationsViktor Ljungström, Diego Cortese, Emma Young, et al.Haematologica|May 21, 2016
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptorsLesley-Ann Sutton, Emma Young, Panagiotis Baliakas, et al.The Journal of Pathology|November 29, 2018
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferationsAliki Xochelli, Vasilis Bikos, Eleftheria Polychronidou, et al.The Lancet. Haematology|April 1, 2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre studyPanagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, et al.Leukemia|September 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC studyAndrea Visentin, Enrico Gaffo, Moritz Fürstenau, et al.Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesAliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, et al.Pageof 5